<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Unilateral <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya disease</z:e> presents as unilateral stenosis or obstruction of the supraclinoid internal carotid artery, which causes <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> resulting in <z:hpo ids='HP_0001250'>seizures</z:hpo> or <z:hpo ids='HP_0002326'>TIA</z:hpo>-like attacks </plain></SENT>
<SENT sid="1" pm="."><plain>In severe cases, surgical treatment is performed with superficial temporal artery-middle cerebral artery anastomosis </plain></SENT>
<SENT sid="2" pm="."><plain>In mild cases, conservative management is the treatment of choice </plain></SENT>
<SENT sid="3" pm="."><plain>Flunarizine is a <z:chebi fb="0" ids="39124">calcium ion</z:chebi> anti-blocking agent, whose primary effect is that the cerebral vessels have been used for the treatment of postcerebrovascular disorders </plain></SENT>
<SENT sid="4" pm="."><plain>Recently, it has been suggested that flunarizine could be used to treat <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>This report documents the efficacy of flunarizine to improve regional cerebral perfusion in <z:e sem="disease" ids="C0026654" disease_type="Disease or Syndrome" abbrv="MYMY|MYMY1">Moyamoya disease</z:e> </plain></SENT>
</text></document>